TP53 and ovarian serous adenocarcinoma: Regardless of origin, two recent meta-analyses of human microarray data both concluded that the pathways most frequently disrupted in platinum-based chemotherapy-resistant, high-grade serous ovarian cancer are p53 and transforming growth factor beta (TGFβ) [12], [13].